FDA approves new treatment for rare genetic disease PKU
BioMarin, Biotech, phenylalanine, PKU, rare disease
0 Comment
Novel enzyme therapy will treat adults with PKU who have uncontrolled blood phenylalanine concentrations with current treatment.